Private Practice & Consultants
For law firms and consultancies of all sizes, the 5th anniversary of The Pharma & Biotech Patent Litigation Europe event offers a unique opportunity to stay at the forefront of life sciences patent litigation. With a 50% in-house counsel audience, this conference provides an exclusive platform to connect with key decision-makers, develop new client relationships, and showcase expertise in UPC litigation, cross-border disputes, and regulatory developments. Whether you're a boutique firm looking to expand your presence or a global practice seeking high-value engagements, this event delivers unmatched networking, thought leadership, and business development opportunities to help you thrive in the evolving pharmaceutical and biotech legal landscape.
Your Benefits
- Direct Access to In-House Counsel: With a 50% in-house counsel audience, law firms have an exclusive opportunity to connect with potential clients, understand their legal challenges, and offer tailored solutions.
- High-Value Business Development Opportunities: Engage in dedicated networking sessions, private meetings, and roundtables to build relationships with key decision-makers in the life sciences industry, leading to potential new mandates.
- Showcasing Expertise & Thought Leadership: Law firms can elevate their brand by speaking on panels, leading discussions, and contributing to thought leadership on cutting-edge patent litigation topics, reinforcing their market presence.
- Exclusive Exposure to Global IP and Regulatory Trends: Stay informed on emerging trends in UPC litigation, cross-border patent enforcement, and European regulatory changes, helping law firms proactively advise their clients.
- Competitive Intelligence & Benchmarking: Gain insights into the strategies of competing law firms, major players in biotech and pharma litigation, and upcoming legal challenges, providing an edge in client representation.
